The quasi-vaccine could help healthcare workers weather a virus outbreak in the future.

The quasi-vaccine could help healthcare workers weather a virus outbreak in the future.
A new nanocarrier-based cancer vaccine used for the treatment of an aggressive and lethal form of skin cancer has been tested on mice, showing promising results.
Scientists integrate light therapy and antibiotics into a single platform to help the body create its own tumor vaccine.
SARS-CoV-2 marker used to trigger the immune system against cancer, showing promise in shrinking tumors and improving survival in mice.
Based on the same mRNA vaccine against COVID-19, a new prototype has shown potential to treat asthma, a condition with no known cure.
Researchers use enzymes to link antigens and adjuvants, creating safer and more effective vaccines by lowering the required adjuvant dosage.
A vaccine to prevent melioidosis, a tropical bacterial disease and possible bioterrorism threat, succeeded in initial trials.
An RNA-based vaccine approach that is effective against all virus strains and safe for infants and immunocompromised individuals.
Microneedle skin patches combined with a safe electrical current help antigens cross the skin to trigger an immune response against tumors.
Researchers are working to decrease the patient discomfort experienced during vaccination